PAVmed Inc reports results for the quarter ended in March - Earnings Summary

PAVmed

17/05/2023 14:31

* PAVmed Inc  PAVM.OQ  reported a quarterly adjusted loss
of 19
cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 21 cents per share.
    * Revenue rose 136% to $446.00 thousand from a year ago;
analysts
expected $400.00 thousand. 
    * PAVmed Inc's reported EPS for the quarter was a loss of 19
cents​.
    * The mean earnings estimate of analysts had risen by
about 4.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * PAVmed Inc shares had risen by 39.0% this quarter and
gained 8.1% so far this year.
    * The company reported a quarterly loss of $18.01 million.
    * Wall Street's median 12-month price target for PAVmed Inc
is
$1.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
17 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.21          -0.19          Beat
 Dec. 31 2022      -0.25          -0.23          Beat
 Sep. 30 2022      -0.26          -0.29          Missed
 Jun. 30 2022      -0.23          -0.29          Missed